EULAV Asset Management’s Sanofi SNY Stock Holding History

EULAV Asset Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-61,000	Closed	-$3.02M	–	325
2015 Q2	$3.02M	Sell	61,000 -17,000	-22%	-$862K	0.16%	191
2015 Q1	$3.86M	Hold	78,000	–	–	0.2%	170
2014 Q4	$3.56M	Buy	78,000 +3,000	+4%	+$146K	0.19%	169
2014 Q3	$4.23M	Buy	75,000 +41,800	+126%	+$2.25M	0.23%	153
2014 Q2	$1.76M	Hold	33,200	–	–	0.09%	272
2014 Q1	$1.74M	Hold	33,200	–	–	0.09%	274
2013 Q4	$1.78M	Buy	33,200 +3,000	+10%	+$155K	0.1%	269
2013 Q3	$1.53M	Sell	30,200 -800	-3%	-$40.7K	0.09%	282
2013 Q2	$1.6M	Buy	+31,000	New	+$1.65M	0.1%	271

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

EULAV Asset Management's SNY Position: Q3 2015 in Review

EULAV Asset Management sold out of Sanofi (SNY) in Q3 2015, closing a stake of 61,000 shares — an estimated $3.02M sold.

EULAV Asset Management first reported a position in SNY in Q2 2013 and held it in 9 quarters. The position peaked at $4.23M in Q3 2014. 500 funds tracked by Wall St. Rank hold SNY as of Q3 2015.

EULAV Asset Management reported no remaining Sanofi position as of Q3 2015 after selling out during the quarter.
EULAV Asset Management sold 61,000 Sanofi shares in Q3 2015, an estimated $3.02M.
EULAV Asset Management first reported a position in Sanofi in Q2 2013 and held it in 9 quarters.
EULAV Asset Management's Sanofi position peaked at $4.23M in Q3 2014.
500 funds tracked by Wall St. Rank held Sanofi as of Q3 2015.

Based on EULAV Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.